Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Concord grape is a specific variety of grape (*Vitis labrusca*) known for its rich content of polyphenolic compounds, including anthocyanins, flavanols, procyanidins, and flavonols. Products derived from Concord grapes, such as juice, extract, puree, and pomace, are extensively studied for their potential health benefits. Research indicates its involvement in modulating glycemic response, enhancing cognitive function, improving cardiovascular health through effects on endothelial function and blood pressure, and positively influencing the gut microbiota. It also exhibits anti-inflammatory and antioxidant properties, which are being explored for their role in stress-related disorders and gut health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Concord grape.